Prophylaxis for surgical site infection (SSI) is often at variance with guidelines, despite the prevalence of SSI and its associated cost, morbidity, and mortality. The CareTrack Australia study, undertaken by a number of the authors, demonstrated that appropriate care (in line with evidence-or consensus-based guidelines) was provided at 38% of eligible SSI healthcare encounters. Here, we report the indicator-level CareTrack Australia findings for SSI prophylaxis. Indicators were extracted from Australian and international clinical guidelines and ratified by clinical experts. A sample designed to be representative of the Australian population was recruited (n=1154). Participants' medical records were reviewed and analysed for compliance with the five SSI indicators. The main outcome measure was the percentage of eligible healthcare encounters with documented compliance with indicators for appropriate SSI prophylaxis. Of the 35,145 CareTrack Australia encounters, 702 (2%) were eligible for scoring against the SSI indicators. Where antibiotics were recommended, compliance was 49% for contaminated surgery, 57% for clean-contaminated surgery and 85% for surgery involving a prosthesis: these fell to 8%, 10% and 14%, respectively (an average of 11%), when currently recommended timing of antibiotic administration was included. Where antibiotics were not indicated, 72% of patients still received them. SSI prophylaxis in our sample was poor; over two-thirds of patients were given antibiotics, whether indicated or not, mainly at the wrong time. There is a need for national agreement on clinical standards, indicators and tools to guide, document and monitor SSI prophylaxis, with both local and national measures to increase and monitor their uptake.
Surgical site infection (SSI) is the most frequent adverse event in Australia and occurs after 2% to 13% of procedures, depending on the type of surgery [1] [2] [3] . Approximately half of all SSI cases are thought to be preventable 4, 5 . SSI increases patient morbidity, mortality, and length-of-stay, costing an estimated $268 million per annum in Australia 2 . National guidelines for preventing SSI have been developed in a number of countries [6] [7] [8] [9] , including Australia 1, 6, 10 , but compliance is poor. For example, inappropriate use of prophylactic antimicrobials, in particular regard to the timing and duration of administration, ranges from 30% to 90% 1 
.
Inadequate SSI prophylaxis has far-reaching implications such as the emergence of resistant bacteria, patient harm, and opportunity costs 1 
There is an urgent need to move towards being able to monitor the appropriateness of care ("care in line with evidence-or consensus-based guidelines") 11, 12 . The CareTrack Australia (CTA) study, undertaken by a number of the authors, was designed to establish baseline estimates of the appropriateness of care delivered, at a population level, by a full range of practitioners in real-world settings, and to determine what would be needed to monitor the ongoing appropriateness of care 12 . Prior to the publication of the CTA study, no comprehensive population study had been undertaken that measured the appropriateness of healthcare received by Australians for 22 common conditions. Similarly, although there had been many previous studies on SSI, most were single-centre rather than population-based, did not include timing of antibiotic prophylaxis, or did not include a full range of procedures. CTA showed that, overall, adult Australians received appropriate care for 22 common conditions at only 57% of eligible healthcare encounters during 2009 and 2010 and at only 38% for SSI 13 . The aim of the current paper is to describe and report indicator-level CTA findings for SSI prophylaxis in the Australian population for a full range of surgery types.
Materials and methods
The CTA methods have been outlined elsewhere 12, 13 . Here, we describe some aspects of SSI prophylaxis; in particular, the use and timing of antibiotics.
Development and ratification of indicators
Although there are many factors that can reduce SSI, CTA focused on three indicators related to appropriateness and timing of prophylactic antibiotics, as suggested by the National Institute of Clinical Excellence 14 . These indicators were sent to four infectious disease specialists, who were heads of departments, asking them to comment on and rate each on a scale of 1 to 9 for appropriateness in the Australia context during 2009 and 2010 15 . Reviewers were also asked to suggest improvements and additional indicators. All reviewers scored the indicators as clearly appropriate, but made suggestions. The first indicator, relating to types of surgery, was split into three (indicators 37 to 39) ( Table 1) . No changes were made to the second (indicator 40: surgery where antibiotic prophylaxis is not indicated). The third indicator (indicator 41: dealing with the timing of antibiotic administration) was updated to reflect the latest evidence at the time of the study (2009 and 2010) 16 .
Recruitment of participants and healthcare providers
A sample designed to be representative of the adult Australian population was randomly selected from a phone directory (the Telstra White Pages) from defined regions within South Australia and New South Wales 12, 13 . One adult was randomly selected from each household and recruited via the telephone. Those who agreed were mailed a package containing information about the study and a consent form to allow access to their medical records. Participants who provided consent were called back and asked if they had been admitted overnight to a hospital or had one or more of the CTA conditions, and which healthcare providers they had seen for these in 2009 
Review of medical records
Medical record reviews were undertaken for the 1154 consenting participants whose healthcare providers had also provided consent. Healthcare encounters were deemed eligible for scoring of SSI indicators if a participant had been admitted overnight and required surgery during 2009 and/ or 2010. Experienced registered nurses were recruited and trained to conduct medical record reviews using a web-based tool for on-site encrypted data collection. A training manual provided inclusion and exclusion criteria and instructions for scoring indicators. Estimates for compliance were measured as the percentage of eligible encounters 12 for the SSI indicators that were answered 'yes'. The inclusion criteria for the indicators were specific to particular types of surgery (e.g. cleancontaminated, contaminated) and timing of administration. Compliance results for some clinically related indicators were aggregated, e.g. administration and timing of an antibiotic for a surgical type.
Statistical analysis
Mean compliance and associated 95% confidence intervals (CI), using a modified version of the Clopper-Pearson (exact) method, were obtained using the SURVEYFREQ procedure in SAS version 9.3 for Windows (SAS Institute, Cary, NC, USA). To address biases arising from the study design (including non-responders), two different weighting options and five versions of weights (three based on approaches in the similar US study 15 ) were used to generate different weighted estimates of compliance 13 . These were not significantly different to unweighted compliances overall or for any condition (including SSI). Hence, unweighted compliances are reported in this analysis. Detailed methodology and results are outlined in the CTA study 13 .
Results
A total of 702 (2%) of the 35,145 CTA encounters (with duplicates removed) were eligible for scoring against the SSI indicators. Of the 1154 CTA participants, 344 (30%) had one or more surgical procedures. The mean age was 63 years (4% were aged 18 to 39, 18% 40 to 54, 61% 55 to 74 and 17% were over 70 years of age) and 202 (59%) were female. Data was collected from 26 hospitals.
Overall compliance for the SSI indicators was 38% (CI 95%, 28% to 49%) ( Table 1) . Compliance ranged from 85% (CI 95%, 77% to 91%) for patients who received prostheses (indicator 37), to 57% (CI 95%, 37% to 76%) for clean-contaminated (indicator 38) and 49% (CI 95%, 7% to 92%) for contaminated surgery (indicator 39). Aggregating indicators 37, 38 and 39, 67% of surgical patients received an antibiotic when indicated. When not indicated (indicator 40), 72% of surgical patients received antibiotics, yielding 28% (CI 95%, 18% to 40%) compliance.
Factoring in correct timing and administration (indicators 37, 38, 39 and indicator 41), compliance fell from 85% to 14% for placement of a prosthesis, from 57% to 10% for clean contaminated surgery and from 49% to 8% for contaminated surgery, reducing average overall compliance to 11%.
Discussion
SSI has been shown to be the most frequent adverse event in Australia 3 . Overall, CTA patients received prophylactic antibiotics for SSI about two-thirds of the time, whether they were indicated or not, with compliance falling to between 8% and 14% (11% overall average) when correct timing of administration was factored in. .
Only one other study was identified where the range of indicators was comparable to our CTA study 7 . This singlecentre prospective Italian study reported compliance for SSI indicators of 45% 7 compared with 38% for CTA 13 . Although other studies provide comparisons to some CTA indicators, for surgery where a prophylactic antibiotic is recommended, the compliances observed in the CTA study were lower at both individual and aggregate indicator level (see Figure 1 and Appendix 1 [online]).
CTA compliance for appropriate timing of antibiotics was only 16%, similar to a national figure in the United States (16%) in 2005 17 and a pay-for-performance hip/ knee replacement study (13%) 18 . Reports of appropriate prescribing of antibiotics range from 53% to 98% 8, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] , but compliance falls dramatically when correct timing is factored in, as with CTA (11%).
While it is difficult to link rates of SSI to one or more process measures (e.g. correct drug, appropriate timing) or risk factors (surgical or patient characteristics) 19 , there is a substantial body of literature on the incidence, attributable costs and adverse outcomes of SSI 34 . Two North American studies on colorectal surgery demonstrated a decrease (22% to 4% and 14% to 9%) in the rate of SSI associated with the administration of the correct antibiotic at the correct time 35, 37 . Optimal timing of antibiotic prophylaxis is often problematic, as the start time of surgery may be difficult to predict 18 because of delays during setup (such as patient positioning) and induction of anaesthesia 17 . Nevertheless, narrower time windows have been achieved 38 . Our indicator for timing of prophylactic antibiotics was 30 to 60 minutes before incision and was based on a large study of single-dose prophylaxis 16 which demonstrated higher SSI rates when prophylaxis was administered either side of this window; this finding has been supported by other studies 39, 40 . This is a more stringent indicator than the "within 60 minutes prior to incision" indicator used in the US Surgical Care Improvement Project (SCIP) (Appendix 2 [online]) which may, in part, explain the lower compliance in our study. Use of the 60-minute interval has been criticised 41 , as administration nearer to incision may not allow adequate time for surgical site antimicrobial tissue levels to be achieved 18 . Prophylactic antibiotics are not recommended for patients having clean, non-prosthetic, uncomplicated surgery (indicator 40) 14 . In the CTA study, 72% of the 141 participants in this group received antibiotics when they were not normally indicated. However, there may be legitimate reasons to administer antibiotics to some of these patients (such as those having vascular or cardiac surgery or with heart valve lesions); these were not explicitly defined for the CTA study. If these had been included in the exclusion criteria for eligibility, the compliance for this indicator may have been higher. Some barriers to appropriate prophylaxis relate to practitioner behaviour and perceptions and some to system deficiencies. Perceptions of practitioners include feelings of lack of ownership, lack of 'clinical agreement', loss of flexibility and professional autonomy and an aversion to using pre-packaged clinical management plans, beliefs that following guidelines can be burdensome and irrelevant to patient care, and lack of knowledge of appropriate practices 1, 22, 42 . System barriers include a lack of up-to-date protocols and no or poor support for their implementation 1 . In addition, it may be unclear to practitioners what constitutes best practice, as studies which had been used to develop guidelines may be out of date, new antibiotics may have emerged and susceptibility patterns may have changed 43 . The development of guidelines, inclusive of correct drug, timing, dose and route for different types of surgery, combined with appropriate implementation strategies can increase compliance with appropriate antibiotic prophylaxis indicators from 50% to 90% 8 . Further, SSI surveillance programs have proven beneficial in reducing surgical wound infections by 35% 6 . Interventions in the US to address SSIs have reduced antibiotic resistance, morbidity, mortality and costs 22, 28, 32, 44, 45 . For example, the Surgical Infection Prevention project in 2002 focused on the correct administration of prophylactic antibiotics 43 and the SCIP aimed to reduce postoperative complications, including SSI, by 25% 46 . Implementation in one US institution resulted in a 33% reduction in SSI for high-risk surgical patients; extrapolated nationally this is the equivalent of 170,000 cases of SSI per year 32 . The national SSI 'bundle' used in the successful SCIP program is presented in Appendix 2 (online). This provides quality indicators that can be used to measure performance and provide a basis for internal and external reporting to assist in the translation of policies Table 2 Strategies to monitor and prevent surgical site infection 1, 6, 10, 27, 28, 32, 34, 36, 42, 45 Involve respected opinion leaders, including infectious disease specialists and other staff and guidelines into practice, and to improve antibiotic stewardship 9 . It would seem logical to adopt this successful model in Australia. Strategies to monitor and prevent SSI are summarised in Table 2 .
In Australia, both national and state programs have been developed to address SSI 1, 2, 10, 36 . Although some hospitals report to state surveillance programs 1, 2, 10 , only 48% of major centres report nationally 1 . This means that Australian figures on the incidence, cost, mortality and morbidity associated with SSI are incomplete and may be unrepresentative. In 2007, the Australian Commission for Safety and Quality in Health Care declared healthcare-associated infection prevention a national priority 1 and further, in 2011, mandated the National Safety and Quality Service Standards for hospital accreditation 4 , which included prevention of SSI within Standard 3. This standard requires the surveillance, prevention and control of healthcare-associated infections and antimicrobial use and stipulates "systems and governance for infection prevention, control and surveillance must be consistent with the relevant national documents, including Australian guidelines for the prevention and control of infections in healthcare". However, this document does not mandate which definitions to use for SSI detection, nor requires reporting to a national body 4 . The key strength of the CTA study is that it is designed to be representative of the Australian population rather than a convenience-or purposive-based sample. However, an unavoidable consequence of this strategy, coupled with finite research funds, is that the number of participants and/or eligible encounters are low for some indicators.
The approach used was associated with a high rate of attrition of potential participants and several sources of bias. However, weighting using two methods and five different options made no difference to the overall compliance percentage or that of SSI. This is consistent with providers not altering their clinical practices for patients of different ages, gender or socioeconomic or health-literacy status.
Commentators raised issues with respect to the levels of evidence, choice of indicators, effects of comorbidities and the possibility of care having been provided but not recorded 47, 48 . Compliance was shown to be no different between consensus-and evidence-based recommendations. The CTA indicators were designed to be clinically relevant but not affected by comorbidities. Inter-rater reliability was moderate, but was in line with other studies using implicit medical record review 49 ; and the effect of care received, but not documented, on overall compliance was thought to be generally about 5% and no more than 10% 15, 50 . Also, as discussed above, there are legitimate reasons for using antibiotics in patients having clean, uncontaminated surgery which were not explicitly included in CTA indicators. Finally, with respect to SSI prophylaxis, CTA focused on determining correctly documented compliance against process measures, which included the provision of antibiotic administration and timing using the National Institute of Clinical Excellence guidelines 14 ; whether documentation matched the actions taken could not be determined retrospectively. Other process measures such as hair removal, glucose control and maintenance of normothermia, which are part of the SSI bundle and SCIP, were not considered 10, 19, 37, 42 .
Conclusion
In conclusion, this paper provides some baseline figures for SSI prophylaxis in Australia, showing poor compliance when combining appropriate prophylaxis with the administration of the antibiotic at the right time for all types of surgery at a population level. Compliance was generally poor, although there are pockets of excellence existing in some hospitals and Australian states for the prevention of SSI. One way forward for Australia would be to implement a national program. National clinical standards with indicators and clinical tools are needed for SSI prophylaxis and should include indications depending on surgery type and dose/s, routes, duration and time/s for administration of recommended antimicrobials. These should be based on validated measures and outcome indicators, backed up by local support for engagement and training of hospital staff, with governance and reporting at a national level.
